ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0497

Relationship Between the Complement System and Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis

Adrián Quevedo-Rodríguez1, Marta Hernández-Díaz2, Dara Rodríguez-González22, Fuensanta Gomez-Bernal3, Juan Carlos Quevedo-Abeledo4, Agustín F González-Rivero2, Elena González López5, gonzalo Ocejo-Viñals5, Miguel Angel Gonzalez-Gay6 and ivan Ferraz-Amaro7, 1Hospital de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain, 2Hospital Universitario de Canarias, SANTA CRUZ DE TENERIFE, Spain, 3Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain, 4Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Canarias, Spain, 5Department of Immunology, Marqués de Valdecilla University Hospital (HUMV), Santander, Spain, 6University of Cantabria, Fundación Jimenez Díaz, Madrid, Madrid, Spain, 7Rheumatology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain

Meeting: ACR Convergence 2024

Keywords: Cardiovascular, Carotid Artery Disease, complement, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 16, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular (CV) events and CV mortality. Carotid subclinical atherosclerosis is independently associated with incident CV event rates amongst patients with RA. The complement system has been linked to the both the etiopathogenesis of RA and CV disease. In this study, we aimed to evaluate the association between a comprehensive assessment of the complement system and carotid intima media thickness and carotid plaque in RA patients.

Methods: 430 patients with RA were recruited. Functional assays of the three pathways of the complement system, utilizing new-generation techniques, were assessed. Additionally, serum levels of individual components of the complement system belonging to the three pathways were measured: C1q (classical), lectin (lectin), C2, C4, and C4b (classical and lectin), factor D and properdin (alternative), C3 and C3a (common), C5, C5a, and C9 (terminal), as well as regulators factor I and C1-inhibitor. Subclinical carotid atherosclerosis by ultrasonography was evaluated. Multivariable linear regression analysis was conducted to investigate the association between the complement system and carotid intima media thickness and plaque.

Results: The study population had a mean age of 55 ± 10 years (81% women). Demographic and disease-related characteristics of the participants, frequency of treatment usage, and historical disease-related data are shown in Table 1
The relation of the complement system to carotid ultrasound evaluation is expressed in Figure 1. Regarding cIMT, many positive associations (red in the heatmap) disclosed statistical significance in the univariable analysis. After multivariable analysis that included demographics and traditional CV factors (Model #1 in Figure 1-A), many significant associations were lost (red color decreased in the heatmap). Only C5a maintained a significant and positive relation to cIMT. Due to potential influences from disease activity, medications, and various other factors related to the disease, we conducted an additional multivariable analysis (Model #2 in Figure 1-A). Remarkably, C3a and C5a continued to exhibit a positive and significant relation to cIMT after this full adjustment.
The analysis of the relation between complement system and carotid plaque yielded similar results to the ones of cIMT in the univariable analysis (Figure 1-B). However, after adjustment for age, sex, abdominal circumference, hypertension, diabetes, the use of statins (Model #1 in Figure 1-B), and disease duration, ESR, ACPA positivity and the utilization of NSAIDs and hydroxychloroquine (Model #2 in Figure 1-B), a higher frequency of significant relations between them were found. In this regard, properdin of the alternative route, C1-inhibitor of the classical and lectin cascades, C3 of the common pathway, and C5 and C5a of the terminal, maintained a significant and positive association with the presence of plaque ( Figure 1-B).
Additionally, non-standardized beta coefficients and odds ratios of the relation of complement system to cIMT and carotid plaque are presented in Table 2.

Conclusion: Complement system and subclinical carotid atherosclerosis are linked in patients with RA.

Supporting image 1

Data represent mean ± SD or median (IQR) when data were not normally distributed.
CRP: C reactive protein; ACPA: Anti-citrullinated protein antibodies. NSAID: Nonsteroidal anti-inflammatory drugs; DMARD: disease-modifying antirheumatic drug. TNF: tumor necrosis factor, ESR: erythrocyte sedimentation rate; BMI: body mass index; DAS28: Disease Activity Score in 28 joints; CDAI: Clinical Disease Activity Index; SDAI: Simple Disease Activity Index. Dyslipidemia was defined if one of the following was present: total cholesterol > 200 mg/dL, triglycerides > 150 mg/dL, HDL cholesterol < 40 in men or <50 mg/dL in women, or LDL cholesterol > 130 mg/dL.

Supporting image 2

Figure 1. Heatmap of the relationship between complement system and carotid ultrasound assessment. Values in the cells represent multivariable standardized beta coefficients of the association between complement system (independent variable) and carotid intima media thickness (A) and carotid plaque (B) (dependent variables). Model 1 is adjusted for demographics and traditional cardiovascular factors, and Model 2 for Model 1 + disease related data. CL: classical, LE: lectin, AL: alternative, fI: factor I, fD: factor D. Significant correlation and standardized beta coefficients with a p <0.05 are depicted as *.

Supporting image 3

Model #1 adjusted for age, sex, abdominal circumference, hypertension, type 2 diabetes and the use of statins.
Model #2 adjusted for Model #1 + rheumatoid factor and the use of NSAIDs, methotrexate, hydroxychloroquine and anti-TNF alpha therapies.
Model #1* adjusted for age, sex, abdominal circumference, hypertension, type 2 diabetes and the use of statins.
Model #2* adjusted for Model #1* + disease duration, ESR, ACPA positivity and the utilization of NSAIDs and hydroxychloroquine.
In this analysis complement system is the independent variable and carotid intima media thickness and carotid plaque are the dependent variable.


Disclosures: A. Quevedo-Rodríguez: None; M. Hernández-Díaz: None; D. Rodríguez-González2: None; F. Gomez-Bernal: None; J. Quevedo-Abeledo: None; A. González-Rivero: None; E. González López: None; g. Ocejo-Viñals: None; M. Gonzalez-Gay: None; i. Ferraz-Amaro: AbbVie/Abbott, 5, 6, Celgene, 6, Janssen, 5, Merck/MSD, 5, 6, Pfizer, 6, Roche, 5, 6, sanofi, 6.

To cite this abstract in AMA style:

Quevedo-Rodríguez A, Hernández-Díaz M, Rodríguez-González2 D, Gomez-Bernal F, Quevedo-Abeledo J, González-Rivero A, González López E, Ocejo-Viñals g, Gonzalez-Gay M, Ferraz-Amaro i. Relationship Between the Complement System and Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/relationship-between-the-complement-system-and-subclinical-carotid-atherosclerosis-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relationship-between-the-complement-system-and-subclinical-carotid-atherosclerosis-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology